Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products

5 clinical trials · Sponsor

Sort:Newest first Oldest first

◉ Watch Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products

Record	Firm	Date
Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive" (NCT05715918)	Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products	2022-04-01
An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) (NCT05407142)	Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products	2021-07-07
An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older (NCT05765773)	Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products	2021-07-01
This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 (NCT05046548)	Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products	2020-10-03
Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19 (NCT05083039)	Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products	2020-05-14

Track Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products automatically

Every clearance here is in the API, with alerts when new ones post.